Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial
Launched by ELISA MCALINDON · Jul 11, 2013
Trial Information
Current as of June 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STEMI
- • providing written informed consent
- Exclusion Criteria:
- • contraindication to CMR,
- • atrial fibrillation,
- • claustrophobia,
- • eGFR \< 30
About Elisa Mcalindon
Elisa McAlindon is a dedicated clinical trial sponsor with extensive experience in advancing medical research and innovative therapies. With a strong commitment to enhancing patient outcomes, McAlindon specializes in the design and execution of clinical trials across various therapeutic areas. Her expertise encompasses regulatory compliance, patient recruitment, and data integrity, ensuring that all studies adhere to the highest ethical and scientific standards. Through her leadership, McAlindon aims to foster collaboration among healthcare professionals, researchers, and stakeholders, driving forward the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bristol, Avon, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials